# Trident Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trident-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Total disclosed funding: $5.3M
- Latest round: Series B (May 21, 2014)
- Investors on record: 1

## About

Based in Boston, Massachusetts, US and founded in 2006, Trident Pharmaceuticals, Inc. is a Biotechnology company. The company is involved in the research and development of drugs for autoimmune disorders and allergic diseases.

## Funding rounds

- Series B, May 21, 2014, $0.3M — Advent International
- Series A, Mar 16, 2006, $5M — Advent International

## Investors

- Advent International (https://capitalatlas.ai/funds/advent-international) — Series A, Series B